• Media type: E-Article
  • Title: Metabolic engineering in Streptomyces albidoflavus for the biosynthesis of the methylated flavonoids sakuranetin, acacetin, and genkwanin
  • Contributor: Pérez-Valero, Álvaro; Ye, Suhui; Magadán-Corpas, Patricia; Villar, Claudio J.; Lombó, Felipe
  • Published: Springer Science and Business Media LLC, 2023
  • Published in: Microbial Cell Factories, 22 (2023) 1
  • Language: English
  • DOI: 10.1186/s12934-023-02247-3
  • ISSN: 1475-2859
  • Origination:
  • Footnote:
  • Description: AbstractFlavonoids are important plant secondary metabolites showing antioxidant, antitumor, anti-inflammatory, and antiviral activities, among others. Methylated flavonoids are particularly interesting compared to non-methylated ones due to their greater stability and intestinal absorption, which improves their oral bioavailability. In this work we have stablished a metabolic engineered strain of Streptomyces albidoflavus with enhanced capabilities for flavonoid production, achieving a 1.6-fold increase in the biosynthesis of naringenin with respect to the parental strain. This improved strain, S. albidoflavus UO-FLAV-004, has been used for the heterologous biosynthesis of the methylated flavonoids sakuranetin, acacetin and genkwanin. The achieved titers of sakuranetin and acacetin were 8.2 mg/L and 5.8 mg/L, respectively. The genkwanin titers were 0.8 mg/L, with a bottleneck identified in this producing strain. After applying a co-culture strategy, genkwanin production titers reached 3.5 mg/L, which represents a 4.4-fold increase. To our knowledge, this study presents the first biosynthesis of methylated flavonoids in not only any Streptomyces species, but also in any Gram-positive bacteria.
  • Access State: Open Access